Ceram, the international materials technology company, will be holding a free breakfast forum ‘Re-Engineering Materials - Reduce Waste, Ensure Future Raw Materials Supply and Save Money’ on Friday 14 June ...
[More]
Avid Bioservices, Inc., a wholly owned subsidiary of Peregrine Pharmaceuticals, Inc., today announced that its recent success in qualifying an antibody-dependent, cell-mediated cytotoxicity (ADCC) bioassay will be highlighted in a poster presentation at IBC's 23rd International Intensive Symposium Development, Validation and Maintenance of Biological Assays Conference to be held in Seattle, Washington, May 14-16, 2013.
[More]
In 2012, more than 3 million people had stents inserted in their coronary arteries. These tiny mesh tubes prop open blood vessels healing from procedures like a balloon angioplasty, which widens arteries blocked by clots or plaque deposits. After about six months, most damaged arteries are healed and stay open on their own. The stent, however, is there for a lifetime.
[More]
It's a familiar scenario – a patient receives a medical implant and days later, the body attacks the artificial valve or device, causing complications to an already compromised system.
[More]
Some parts of the body, like the liver, can regenerate themselves after damage. But others, such as our nervous system, are considered either irreparable or slow to recover, leaving thousands with a lifetime of pain, limited mobility, or even paralysis.
[More]
Researchers have made a significant first step with newly engineered biomaterials for cell transplantation that could help lead to a possible cure for Type 1 diabetes, which affects about 3 million Americans.
[More]
Over 20 million people in Europe suffer from osteoarthritis which can lead to extensive damage to the knee and hip cartilage. Stem cells offer a promising way forward but a key challenge has been to design a ‘smart material’ that is biologically effective for cartilage tissue regeneration.
[More]
Spherix Incorporated -- an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis, today announced the signing of a memorandum of understanding (MOU) with ChromaDex to extend the commercial market for D-tagatose, extend the structure function claims for the GRAS food ingredient, and to optimize a new system of D-tagatose production.
[More]
Market leaders in temperature controlled microscopy, Linkam Scientific Instruments report on the use of their popular THMS600 stage for polymer research at the Institute of Chemistry and Technology of Polymers (CNR), Italy.
[More]
ASU engineer Amy Landis has a pivotal role in a new potentially far-reaching effort to use biomaterial to produce rubber in a more environmentally and economically sustainable way.
[More]